By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 112.46 |
Change Today | $ -2.05 |
% Change | -1.79 % |
52 Week High | $117.41 |
52 Week Low | $72.73 |
Volume | 6,132,132 |
Shares Issued | 1,246.00m |
Market Cap | $140,125m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 10 |
Neutral | 7 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
16:00 | 949,169 @ $112.46 |
16:00 | 265 @ $112.49 |
16:00 | 193 @ $112.49 |
15:59 | 300 @ $112.49 |
15:59 | 637 @ $112.49 |
You are here: research